- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00560365
Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer
A Randomised Controlled Trial to Assess the Cost-effectiveness of Intensive Versus no Scheduled Follow-up in Patients Who Have Undergone Resection for Colorectal Cancer With Curative Intent. (FACS - Follow-up After Colorectal Surgery)
RATIONALE: Following patients who have undergone surgery for colorectal cancer may help doctors learn more about the disease and plan better follow-up care.
PURPOSE: This randomized clinical trial is following patients who have undergone surgery for stage I, stage II, or stage III colorectal cancer.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
OBJECTIVES:
Primary
- To assess the effect of augmenting symptomatic follow-up in primary care with two intensive methods of follow-up (monitoring tumor marker in primary care and intensive imaging in hospital) on survival of patients with stage I, II, or III colorectal cancer who have undergone curative resection.
Secondary
- Determine the quality of life of these patients.
- Determine the cost of National Health Service (NHS) services utilized.
- Determine the NHS cost per life-year saved.
OUTLINE: This is a multicenter study. Patients are stratified according to certainty of need for imaging follow-up, as determined by the local clinician (uncertain vs certain). Patients are randomized to 1 of 4 follow-up arms.
- Arm I (primary care follow-up): Patients undergo symptomatic follow-up (i.e., are asked to contact their physician if they have symptoms suggestive of disease recurrence). Some patients may also undergo a single CT scan 12-18 months post-randomization.
- Arm II (primary care follow-up): Patients undergo tumor marker measurements (CEA) at baseline, every 3 months for 2 years, and every 6 months for 3 years. Some patients may also undergo a single CT scan 12-18 months post-randomization.
- Arm III (intensive hospital follow-up): Patients undergo CT scan or MRI at baseline, every 6 months for 2 years, and then annually for 3 years.
- Arm IV (primary care and intensive hospital follow-up): Patients undergo primary care and intensive hospital follow-up as in arms II (without the single CT scan) and III.
All patients receive a handbook from their physician detailing possible symptoms suggestive of disease recurrence.
Quality of life is assessed at baseline and then annually for 5 years.
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiesteder
-
-
England
-
Burton-upon-Trent, England, Det Forenede Kongerige, DE13 0RB
- Rekruttering
- Queen's Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1283-566-333
-
Carlisle, England, Det Forenede Kongerige, CA2 7HY
- Rekruttering
- Cumberland Infirmary
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1228-523-444
-
Chichester, England, Det Forenede Kongerige, P019 4SE
- Rekruttering
- Saint Richards Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1243-788-122
-
Cosham, England, Det Forenede Kongerige, PO6 3LY
- Rekruttering
- Queen Alexandra Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-23-9228-6710
-
Cottingham, England, Det Forenede Kongerige, HU16 5JQ
- Rekruttering
- Castle Hill Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1482-659-331
-
Crewe, England, Det Forenede Kongerige, CW1 4QJ
- Rekruttering
- Mid Cheshire Hospitals Trust- Leighton Hopsital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1270-255-141
-
Croydon, England, Det Forenede Kongerige
- Rekruttering
- Mayday University Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8401-3000
-
Dartford Kent, England, Det Forenede Kongerige, DA2 8DA
- Rekruttering
- Darent Valley Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1322-428-500
-
Derby, England, Det Forenede Kongerige, DE22 3NE
- Rekruttering
- Royal Derby Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1332-340-131
-
Dudley, England, Det Forenede Kongerige, DY1 2HQ
- Rekruttering
- Russells Hall Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1384-456-111
-
Grantham, Lincolnshire, England, Det Forenede Kongerige, NG31 8DG
- Rekruttering
- Grantham and District Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1476-565-232
-
Harrogate, England, Det Forenede Kongerige, HG2 7SX
- Rekruttering
- Harrogate District Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1423-885-959
-
Harrow, England, Det Forenede Kongerige, HA1 3UJ
- Rekruttering
- St. Mark's Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8235-4000
-
High Wycombe, England, Det Forenede Kongerige
- Rekruttering
- Wycombe General Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1494-426-234
-
Huntingdon, England, Det Forenede Kongerige, PE18 6NT
- Rekruttering
- Hinchingbrooke Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1480-416-416
-
Isleworth, England, Det Forenede Kongerige, TW7 6AF
- Rekruttering
- West Middlesex University Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8560-2121
-
Leeds, England, Det Forenede Kongerige, LS1 3EX
- Rekruttering
- Leeds General Infirmary
-
Kontakt:
- Contact Person
- Telefonnummer: 44-113-243-2799
-
London, England, Det Forenede Kongerige, W6 8RF
- Rekruttering
- Charing Cross Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8846-1234
-
Maidstone, England, Det Forenede Kongerige, ME16 9QQ
- Rekruttering
- Mid Kent Oncology Centre at Maidstone Hospital
-
Nottingham, England, Det Forenede Kongerige, NG7 2UH
- Rekruttering
- Queen's Medical Centre
-
Kontakt:
- Contact Person
- Telefonnummer: 44-115-924-9924
-
Plymouth, England, Det Forenede Kongerige, PL6 8DH
- Rekruttering
- Derriford Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-175-277-7111
-
Scarborough, England, Det Forenede Kongerige, YO12 6QL
- Rekruttering
- Scarborough General Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1723-342-175
-
Shrewsbury, England, Det Forenede Kongerige, SY3 8XQ
- Rekruttering
- Royal Shrewsbury Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1743-261-000
-
Slough, Berkshire, England, Det Forenede Kongerige, SL2 4HL
- Rekruttering
- Wexham Park Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1753-634-191
-
Solihull, England, Det Forenede Kongerige, B91 2JL
- Rekruttering
- Solihull Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-121-424-2000
-
Southampton, England, Det Forenede Kongerige, SO16 6YD
- Rekruttering
- Southampton General Hospital
-
Surrey, England, Det Forenede Kongerige, KT 16 OPZ
- Rekruttering
- St. Peter's Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1932-722-233
-
Truro, Cornwall, England, Det Forenede Kongerige, TR1 3LJ
- Rekruttering
- Royal Cornwall Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1872-250-000
-
Uxbridge, England, Det Forenede Kongerige, UB8 3NN
- Rekruttering
- Hillingdon Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1895-238-282
-
Warrington, England, Det Forenede Kongerige, WA5 1QG
- Rekruttering
- Warrington Hospital NHS Trust
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1925-635-911
-
Worcester, England, Det Forenede Kongerige, WR5 1DD
- Rekruttering
- Worcester Royal Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1905-760-719
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
DISEASE CHARACTERISTICS:
Diagnosis of primary colorectal cancer
- Stage I-III disease
Have undergone curative resection (i.e., no residual disease [R0])
- Microscopically clear margins
- Complete normal colonic imaging pre-operatively (or post-operatively if unable to view complete colon pre-operatively) by colonoscopy, barium enema, CT pneumocolon, or virtual colonoscopy
Post-operative blood CEA ≤ 10 ng/mL (if the normal range is ≤ 5 ng/mL) OR < 2 times upper limit of normal (if normal range is > 5 ng/mL)
- For patients undergoing adjuvant therapy, CEA should be measured after completion of chemotherapy
Has completed primary curative treatment, as deemed by hospital clinician
- Patients awaiting stoma closure allowed
- No evidence of metastatic disease on pre- or post-operative liver CT scan (or ultrasound) and chest CT scan (or chest x-ray)
- No diagnosis of familial adenomatous polyposis (FAP) or dominantly inherited colon cancer
PATIENT CHARACTERISTICS:
- No concurrent serious illness
- History of other carcinoma allowed provided primary treatment has been completed, there is no evidence of recurrent disease, and there is no follow-up that conflicts with study follow-up
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- Pre-operative radiotherapy or chemoradiotherapy for rectal cancer allowed provided curative resection has been achieved
- No concurrent participation in a primary treatment clinical trial with conflicting follow-up requirements
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
|---|
|
Overall survival by intention-to-treat analysis
|
Sekundære resultatmål
Resultatmål |
|---|
|
Livskvalitet
|
|
Cost of National Health Service (NHS) services utilized
|
|
NHS cost per life-year saved
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studiestol: John N. Primrose, MD, University Hospital Southampton NHS Foundation Trust
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CDR0000576476
- USCTU-FACS
- ISRCTN41458548
- EU-20788
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kolorektal cancer
-
University of ArkansasRekrutteringColorectal cancer og inflammatorisk tarmsygdomForenede Stater
-
University Health Network, TorontoAstraZenecaAktiv, ikke rekrutterendeAdenocarcinom i bugspytkirtlen | Leiomyosarkom | Mismatch Reparation Proficient Colorectal CancerCanada
-
Stingray TherapeuticsRekrutteringRefractory Metastatic Microsatellite Stabil Colorectal Cancer (MSS-CRC)Forenede Stater
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaIkke rekrutterer endnuKolorektal kirurgi | Robotkirurgi | Colorectal cancer og inflammatorisk tarmsygdom
-
Tianjin Medical University Cancer Institute and...RekrutteringMSI-H Advanced Colorectal CancerKina
-
Bristol-Myers SquibbAfsluttetMikrosatellit stabil kolorektal cancer | Mismatch Reparation Proficient Colorectal Cancer | Mikrosatellit ustabil kolorektal cancer | Mismatch Reparation Manglende tyktarmskræftForenede Stater, Australien, Belgien, Canada, Irland, Italien, Spanien, Frankrig
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCAfsluttetMelanom | Ikke-småcellet lungekræft | Mismatch Reparation-Proficient Colorectal CancerForenede Stater
Kliniske forsøg med computertomografi
-
Hospices Civils de LyonAfsluttetCochleære implantaterFrankrig
-
Central Hospital, Nancy, FranceAfsluttet
-
Peking Union Medical College HospitalRekruttering
-
University Hospital, Strasbourg, FranceAfsluttet
-
University of BernITI FoundationAfsluttet
-
GE HealthcareFortreaRekrutteringKolorektal cancer | Duktalt adenokarcinom i bugspytkirtlen | Mavekræft | Kræft i æggestokkeneSverige, Forenede Stater
-
University Hospital, ToulouseAfsluttetSinonasale patologierFrankrig
-
Istituto Ortopedico RizzoliAfsluttetPatello femoralt syndromItalien
-
Hospices Civils de LyonUkendt
-
Maastricht University Medical CenterAdvanced BionicsUkendtCochlear implantation | Cone-Beam computertomografiHolland